BCAL Diagnostics (ASX:BDX) Other Current Payables: A$0.00 Mil (As of Dec. 2025)


What is BCAL Diagnostics Other Current Payables?

BCAL Diagnostics ASX:BDX -1.39% Other Current Payables is A$0.00 Mil as of Dec. 2025. The stock has 3 warning signs investors should review.

BCAL Diagnostics's Other Current Payables for the quarter that ended in Dec. 2025 was A$0.00 Mil.

BCAL Diagnostics's quarterly Other Current Payables increased from Dec. 2024 (A$0.00 Mil) to Jun. 2025 (A$0.65 Mil) but then declined from Jun. 2025 (A$0.65 Mil) to Dec. 2025 (A$0.00 Mil).

BCAL Diagnostics's annual Other Current Payables increased from Jun. 2023 (A$0.44 Mil) to Jun. 2024 (A$1.29 Mil) but then declined from Jun. 2024 (A$1.29 Mil) to Jun. 2025 (A$0.65 Mil).

BCAL Diagnostics Other Current Payables Related Terms

BCAL Diagnostics Other Current Payables Historical Data

* Premium members only.

The historical data trend for BCAL Diagnostics's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BCAL Diagnostics Other Current Payables Chart

BCAL Diagnostics Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Other Current Payables
0.64 0.44 1.29 0.65

BCAL Diagnostics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 1.29 0.00 0.65 0.00

BCAL Diagnostics Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of A$0.00 Mil mean?
BCAL Diagnostics (ASX:BDX) has a Other Current Payables of A$0.00 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on BCAL Diagnostics and its competitors.
Is BCAL Diagnostics' Other Current Payables too high?
BCAL Diagnostics' current Other Current Payables is A$0.00 Mil.
How does BCAL Diagnostics' Other Current Payables compare to TMO and DHR?
BCAL Diagnostics' Other Current Payables of A$0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Diagnostics & Research company?
A good Other Current Payables depends on the Medical Diagnostics & Research industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on BCAL Diagnostics and its competitors. BCAL Diagnostics's current Other Current Payables is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BCAL Diagnostics stock overvalued right now?
BCAL Diagnostics (ASX:BDX) has a current Other Current Payables of A$0.00 Mil. The current Other Current Payables is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For BCAL Diagnostics (ASX:BDX), the current Other Current Payables is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BCAL Diagnostics Business Description

Address 50 Clarence Street, Suite 506, Level 5, Sydney, NSW, AUS, 2000
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer that is safe, cost-effective, accurate, and available to all women regardless of age, race, and geographic location.